ArticleBJC reports2025

Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort.

Annelie Augustinsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.